Jialan Zang

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin

Yong Hu, Jialan Zang, Xiaobing Qin et al. · OncoTargets and Therapy · 2017 · 30 citations · Full text

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

Jialan Zang, Yong Hu, Xiaoyue Xu et al. · OncoTargets and Therapy · 2017 · 19 citations · Full text

Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation

Yong Hu, Xiaobing Qin, Dali Yan et al. · Tumor Biology · 2017 · 18 citations · Full text

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB <i>in vitro</i>

Yong Hu, Jialan Zang, Haixia Cao et al. · Oncotarget · 2017 · 16 citations · Full text

Immunology, Cell Death, Pathology +20

MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment

Xiaoyue Xu, Shaorong Yu, Wenbo Sun et al. · Journal of Cancer Research and Clinical Oncology · 2017 · 11 citations · Full text

Mirna Signature, Oncology, Medicine +11